JP2005522452A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005522452A5 JP2005522452A5 JP2003567882A JP2003567882A JP2005522452A5 JP 2005522452 A5 JP2005522452 A5 JP 2005522452A5 JP 2003567882 A JP2003567882 A JP 2003567882A JP 2003567882 A JP2003567882 A JP 2003567882A JP 2005522452 A5 JP2005522452 A5 JP 2005522452A5
- Authority
- JP
- Japan
- Prior art keywords
- benzo
- tetrahydro
- azepine
- alkyl
- phenylsulfonamido
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0203437A GB0203437D0 (en) | 2002-02-13 | 2002-02-13 | Novel compounds |
| GB0204758A GB0204758D0 (en) | 2002-02-28 | 2002-02-28 | Novel compounds |
| GB0212548A GB0212548D0 (en) | 2002-05-30 | 2002-05-30 | Novel compounds |
| GB0219711A GB0219711D0 (en) | 2002-08-23 | 2002-08-23 | Novel compounds |
| PCT/EP2003/001543 WO2003068751A1 (en) | 2002-02-13 | 2003-02-13 | 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5-ht6 receptor affinity for the reatment of cns disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005522452A JP2005522452A (ja) | 2005-07-28 |
| JP2005522452A5 true JP2005522452A5 (cg-RX-API-DMAC7.html) | 2006-01-05 |
Family
ID=27739230
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003567882A Pending JP2005522452A (ja) | 2002-02-13 | 2003-02-13 | Cns疾患の治療のための、5−ht6受容体アフィニティーを有する7−アリールスルホンアミド−2,3,4,5−テトラヒドロ−1h−ベンゾ’ジアゼピン誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20050090485A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1487801B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005522452A (cg-RX-API-DMAC7.html) |
| AR (1) | AR038421A1 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE323680T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003206909A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE60304695T2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2260607T3 (cg-RX-API-DMAC7.html) |
| TW (1) | TW200306843A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003068751A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003068732A2 (en) * | 2002-02-13 | 2003-08-21 | Glaxo Group Limited | Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds |
| PL371344A1 (en) * | 2002-02-13 | 2005-06-13 | Glaxo Group Limited | Benzenesulfonamide derivatives as antipsychotic agents |
| AR039127A1 (es) * | 2002-03-27 | 2005-02-09 | Glaxo Group Ltd | Compuesto de quinolina, procedimiento para su preparacion, composicion farmaceutica que lo comprende y uso del mismo para la fabricacion de un medicamento |
| MY133587A (en) | 2002-05-29 | 2007-11-30 | Glaxo Group Ltd | Aromatic sulfones and their medical use |
| NZ544331A (en) | 2003-07-22 | 2010-03-26 | Arena Pharm Inc | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto |
| GB0329214D0 (en) * | 2003-12-17 | 2004-01-21 | Glaxo Group Ltd | Novel compounds |
| US8207160B2 (en) * | 2003-12-18 | 2012-06-26 | Abbott Gmbh & Co. Kg | Tetrahydrobenzazepines and their use in he modulation of the dopamine D3 receptor |
| US20050137186A1 (en) * | 2003-12-18 | 2005-06-23 | Abbott Gmbh & Co. Kg. | Tetrahydrobenzazepines and their use |
| TW200611701A (en) * | 2004-06-18 | 2006-04-16 | Glaxo Group Ltd | Novel compounds |
| EP1809619A1 (en) * | 2004-10-21 | 2007-07-25 | Transtech Pharma, Inc. | Bissulfonamide compounds as agonists of galr1, compositions, and methods of use |
| EP1910321A4 (en) * | 2005-07-05 | 2010-09-01 | Astrazeneca Ab | NEW COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF, INTERMEDIATE PRODUCTS, PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT OF 5-HT6-MEDIATED ILLNESSES SUCH AS ALZHEIMER'S DISEASE, COGNITIVE ILLUSTRATIONS, SCHOISOPHRENIC ASSOCIATED COGNITIVE DISORDERS, OBESITAS AND PARKINSON DISEASE |
| CN101258136A (zh) * | 2005-07-05 | 2008-09-03 | 阿斯利康(瑞典)有限公司 | 新化合物、其制备方法、中间体、药物组合物和其在治疗5-ht6介导的疾病例如阿尔茨海默病、认知障碍、精神分裂症相关的认知缺损、肥胖和帕金森病中的用途 |
| EP2120950B1 (en) * | 2007-03-21 | 2012-07-04 | Glaxo Group Limited | Use of quinoline derivatives in the treatment of pain |
| EP2254564A1 (en) | 2007-12-12 | 2010-12-01 | Glaxo Group Limited | Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline |
| WO2009123714A2 (en) | 2008-04-02 | 2009-10-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| US9126946B2 (en) | 2008-10-28 | 2015-09-08 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto |
| CN103145619A (zh) * | 2012-06-15 | 2013-06-12 | 史慎德 | 7-氯-6-苯磺酰氨基-2,3,4,5-四氢-1H-苯并[d]氮杂*的制备 |
| JP2018516992A (ja) | 2015-06-12 | 2018-06-28 | アクソファント サイエンシーズ ゲーエムベーハーAxovant Sciences Gmbh | レム睡眠行動障害の予防および処置のために有用なジアリールおよびアリールヘテロアリール尿素誘導体 |
| CN108472285A (zh) | 2015-07-15 | 2018-08-31 | 阿速万科学有限责任公司 | 用于预防和治疗与神经退行性疾病相关联的幻觉的二芳基和芳基杂芳基脲衍生物 |
| JP6929857B2 (ja) | 2016-01-15 | 2021-09-01 | ファイザー・インク | 6,7,8,9−テトラヒドロ−5H−ピリド[2,3−d]アゼピンドーパミンD3リガンド |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3314963A (en) * | 1962-07-23 | 1967-04-18 | Pfizer & Co C | Azabenzocycloalkane-n-carboxamidines |
| DE3614863A1 (de) * | 1986-05-02 | 1987-11-05 | Wabco Westinghouse Fahrzeug | Betaetigungseinrichtung fuer eine differentialsperre mit einem stellglied |
| US4978660A (en) * | 1988-06-01 | 1990-12-18 | Smithkline Beecham Corporation | α-adrenergic receptor antagonists |
| US5006521A (en) * | 1988-06-01 | 1991-04-09 | Smithkline Beecham Corporation | α-adrenergic receptor antagonists and methods of use thereas |
| US4959360A (en) * | 1988-06-01 | 1990-09-25 | Smithkline Beecham Corporation | α-adrenergic receptor antagonists |
| US5939451A (en) * | 1996-06-28 | 1999-08-17 | Hoffmann-La Roche Inc. | Use of sulfonamides |
| DZ2376A1 (fr) * | 1996-12-19 | 2002-12-28 | Smithkline Beecham Plc | Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant. |
| IL133870A0 (en) * | 1997-07-11 | 2001-04-30 | Smithkline Beecham Plc | Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation |
| GB9801392D0 (en) * | 1998-01-22 | 1998-03-18 | Smithkline Beecham Plc | Novel compounds |
| GB9803411D0 (en) * | 1998-02-18 | 1998-04-15 | Smithkline Beecham Plc | Novel compounds |
| GB9926302D0 (en) * | 1999-11-05 | 2000-01-12 | Smithkline Beecham Plc | Novel compounds |
| GB0111186D0 (en) * | 2001-05-08 | 2001-06-27 | Smithkline Beecham Plc | Novel compounds |
| PL371344A1 (en) * | 2002-02-13 | 2005-06-13 | Glaxo Group Limited | Benzenesulfonamide derivatives as antipsychotic agents |
| WO2003068732A2 (en) * | 2002-02-13 | 2003-08-21 | Glaxo Group Limited | Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds |
-
2003
- 2003-02-13 US US10/503,678 patent/US20050090485A1/en not_active Abandoned
- 2003-02-13 AU AU2003206909A patent/AU2003206909A1/en not_active Abandoned
- 2003-02-13 JP JP2003567882A patent/JP2005522452A/ja active Pending
- 2003-02-13 DE DE60304695T patent/DE60304695T2/de not_active Expired - Fee Related
- 2003-02-13 ES ES03704631T patent/ES2260607T3/es not_active Expired - Lifetime
- 2003-02-13 EP EP03704631A patent/EP1487801B1/en not_active Expired - Lifetime
- 2003-02-13 AT AT03704631T patent/ATE323680T1/de not_active IP Right Cessation
- 2003-02-13 WO PCT/EP2003/001543 patent/WO2003068751A1/en not_active Ceased
- 2003-02-13 TW TW092102942A patent/TW200306843A/zh unknown
- 2003-02-13 AR ARP030100475A patent/AR038421A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005518414A5 (cg-RX-API-DMAC7.html) | ||
| US11434207B2 (en) | P2X4 receptor antagonist | |
| JP2006505623A5 (cg-RX-API-DMAC7.html) | ||
| JP2021011495A5 (cg-RX-API-DMAC7.html) | ||
| CN103038231B (zh) | Hec1活性调节剂及其方法 | |
| CN110621664B (zh) | 新型哌啶-2,6-二酮衍生物及其用途 | |
| JP2005527542A5 (cg-RX-API-DMAC7.html) | ||
| RU2004131641A (ru) | Новые соединения | |
| RU2005130514A (ru) | 2,5- и 2,6-замещенные тетрагидроизохинолины, предназначенные для применения в качестве модуляторов 5-нт6 | |
| CN103237794B (zh) | P2x4受体拮抗剂 | |
| JP2004534755A5 (cg-RX-API-DMAC7.html) | ||
| JP2009513703A5 (cg-RX-API-DMAC7.html) | ||
| CN105218532B (zh) | 苯并三氮唑类化合物、制备方法和其医药用途 | |
| JP2009537542A5 (cg-RX-API-DMAC7.html) | ||
| KR20030011093A (ko) | 비스-아릴술폰 | |
| JP2008506695A5 (cg-RX-API-DMAC7.html) | ||
| CN107531683A (zh) | Usp7抑制剂化合物及使用方法 | |
| AR038421A1 (es) | Compuesto sulfonamida de 1,2,4,5-tetrahidrobenzo (d) azepina, procedimiento para su preparacion, composicion farmaceutica que lo comprende y su uso para preparar esta ultima | |
| RU2005111590A (ru) | 2,4-замещенные индолы и их использование в качестве модуляторов 5-гт6 | |
| RU2007116987A (ru) | Новые соединения | |
| CN102131791A (zh) | 二苯并硫杂氮杂*衍生物及其用途 | |
| RU2005138147A (ru) | Применение сульфонамидных производных для изготовления лекарственного средства, предназначенного для профилактики и/или лечения нарушений потребления пищи | |
| JP2006504794A5 (cg-RX-API-DMAC7.html) | ||
| JP2005532318A5 (cg-RX-API-DMAC7.html) | ||
| CN107001267A (zh) | 稠合杂环化合物 |